Note: Ingredients listed on restricted chemical lists
EC/CAS
7585-41-3
Name of the chemical
Barium 4- (5-chloro-4-methyl-2-sulphonatophenyl)azo -3-hydroxy-2-naphthoate
Concentration
30.0000-60.0000 15.0000-40.0000
General Information
Revision date
2013-06-26
Product name
Safety (EHS) Phone
Manufacturer Name
INX International Ink Co
Emergency telephone
800.535.5053
Icons in SDS
Company Information
company name
INX International Ink Co
e-mail address of the competent person responsible for the Safety Data Sheet
MSDS@inxintl.com
Hazard Codes
Hazard statements (CLP)
H317
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA HCS Classification
Irritating material Sensitizing material Form This is a Product Line MSDS (PLDS) relevant to multiple but similar printing ink formulations. Accordingly, physical data values are given as ranges representative of the base colors for this product line. Physical data for a specific formulation may be derived from the CPDS (Certified Product Data Sheet). Customers may also request an itemized report of regulated constituents based on sales history for a given period. Emergency overview WARNING MAY CAUSE SKIN IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION. PROLONGED OR REPEATED CONTACT MAY DRY SKIN AND CAUSE IRRITATION. Defatting to the skin. May cause sensitization by skin contact. Do not breathe vapor or mist. Do not get on skin or clothing. Avoid contact with eyes. Wash thoroughly after handling. Routes of entry eyes ingestion skin Inhalation
Potential Acute Health Effects
Eye contact Irritating to eyes. Skin contact Irritating to skin. May cause sensitization by skin contact. inhalation Exposure to decomposition products may cause a health hazard. Serious effects may be delayed following exposure. ingestion No known significant effects or critical hazards. Potential chronic health effects Carcinogenicity No known significant effects or critical hazards. Mutagenicity No known significant effects or critical hazards.
Teratogenic Effects
No known significant effects or critical hazards. Developmental effects :No known significant effects or critical hazards. Fertility effects No known significant effects or critical hazards. Over-exposure signs/symptoms Eye/face No specific data. skin Adverse symptoms may include the following: redness dryness cracking inhalation No specific data. ingestion No specific data. Medical conditions aggravated by over-exposure Pre-existing skin disorders may be aggravated by over-exposure to this product.